Technology Rapid Selection Of High-Value Internalizing Binders For Targeted Therapeutics Lentiviral display platform engineered to directly select and enrich antibodies based on their ability to induce receptor-mediated endocytosis, thereby streamlining the discovery of highly internalizing candidates for targeted therapies The…
News NanoPattern Technologies, ReAx Biotechnologies Receive $150,000 Each to Commercialize Research The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has chosen two companies – NanoPattern Technologies and ReAx Biotechnologies – to invest in as part of the...
News Navigating Startup Success: Polsky Launches the ‘Compass,’ a New Deep Tech Accelerator Program The Polsky Center for Entrepreneurship and Innovation recently launched the Compass – a first-of-its-kind deep tech accelerator program for early-stage startups and technologies. “Backed by a 25-year history of launching...
News 50 Companies to Pitch to Investors at DeepTechU The DeepTechU venture conference will showcase 50 startups during the three-day virtual event May 3 to 5, giving investors an early look at cutting-edge deep tech innovation coming out of universities,...
News 6 UChicago Researchers to Present at Illinois Ignite Researchers from the University of Chicago are showcasing novel technologies and innovative startups at the third biennial Illinois Ignite. The event takes place on September 22, 2022, from 9:00 a.m....
Technology SARS-CoV-2 Monoclonal Antibodies Against Spike and Internal Proteins for Therapeutics and Diagnostics As of February 2021, there have been over 107 million cases and over 2 million deaths caused worldwide by the novel virus SARS-CoV-2. Few vaccination and treatment approaches are currently…
Technology Mesenchymal Stem Cell And Exosome-Based Therapeutics For Restoring Ovarian Function In Premature Ovarian Insufficiency Therapeutic strategy using human mesenchymal stem cells or their exosomes to restore ovarian function and fertility in premature ovarian insufficiency by promoting cell growth, reducing cell death, and enhancing blood…
Technology Small Molecule Therapeutics For Inducing Trained Innate Immunity And Enhanced Anti-Tumor Responses Small molecule drugs developed to induce trained immunity in macrophage cells resulting in a heightened pro-inflammatory response without triggering a primary immune response The Unmet Need: Trained immunity induction that…
Technology Small Molecule Therapeutics For Inhibiting Carotid Body Hypersensitivity To Treat Sleep-Related Breathing Disorders New compounds that inhibit an enzyme to reduce hydrogen sulfide in the carotid body, helping to normalize breathing and prevent sleep apnea by targeting the underlying cause of abnormal breathing…
Technology Antibody-Based Therapeutics For Inhibiting Growth Hormone Receptor Dimerization And Signaling Antibodies that block growth hormone signaling by binding the receptor or hormone to stop receptor pairing, based on high-affinity, defined sequences for therapeutic and research use. The Unmet Need: Effective…
News Fall 2026 Collaboratorium Connects Midwest Researchers with Business Expertise Bringing together scientific innovation and business talent from four leading Midwestern universities, the Fall 2026 Collaboratorium will feature 18 teams developing technologies in healthcare, energy storage, quantum computing, semiconductors, advanced...
Technology AI-Guided Genome-Wide CRISPR Platform for Novel Skin Therapeutics AI-guided CRISPR platform enables precise identification of novel therapeutic targets in primary cells, significantly enhancing drug discovery efficiency and facilitating the development of topical treatments for inflammatory skin diseases such…
